A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.
Clinical trial NCT07622836 · RECRUITING
Trial details
- NCT number
- NCT07622836
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-05
- Primary completion
- 2030-01-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.